HKMB Hong Kong Means Business

Hong Kong Means Business Hong Kong Means Business
  • Login / Register

Languages

  • EN
  • 繁
  • 简
  • Events
  • My Feed
  • Contact HKTDC
  • Subscribe
  • Subscribe

Section Menu

  • Market Opportunities
  • Tech & Innovation
  • Entrepreneurship
  • Sustainability
  • Creativity & Lifestyle
  • HKTDC Updates
  • Featured Topics

Languages

  • EN
  • 繁
  • 简
  • HKTDC.com |
  • About HKTDC |
  • My HKTDC |
  • Login / Register |

HKTDC.com About HKTDC My HKTDC

Login Register

Hong Kong Means Business

Section Menu

  • Market Opportunities
  • Tech & Innovation
  • Entrepreneurship
  • Sustainability
  • Creativity & Lifestyle
  • HKTDC Updates
  • Featured Topics

https://hkmb.hktdc.com/en/qCEPodor

Creativity & Lifestyle
SAVE FOR LATER
SHARE / SEND

"Scan QR Code" in WeChat and tap "..." to share.

Healthcare start-up hits a high note

A medical supply company launched in response to the pandemic found Hong Kong to be the perfect base to grow into a global business.

21 October 2022


A serial entrepreneur based in Hong Kong for more than 20 years, France-born Sophie Martineau set up her medical supplies business Aquila Healthcare under the brand AquilaVIE in 2020. The launch was in response to the COVID-19 pandemic, when demand for personal protective equipment (PPE) such as masks rapidly outpaced supply.

Ms Martineau said one of the most innovative products to result from the company launch is AQ Lollipop, a two-in-one oral/nasal swab suitable for children aged one and up that can detect COVID variants orally by swabbing the cheek instead of inserting it into the nostril. The AquilaVIE product range also includes masks, gloves, syringes and COVID-19 antigen tests.

In a market full of big players, AquilaVIE saw the COVID-generated demand as an opportunity for a young and nimble firm.

AquilaVIE, whose name is derived from the French word vie, meaning “life”, managed to hold its own against stiff competition, Ms Martineau said. “In some ways the pandemic brought to light some structural problems in the industry and allowed a new entrant like us to break into the market. Many of the large global players didn’t manage their supply chains or manufacturing well enough and many customers were left without access to high-quality medical devices and equipment.”

The company has grown quickly and now has regional offices in France, the United States, the United Kingdom and Italy. Headquartered in Hong Kong, its products are made in the city’s neighbour – and Guangdong-Hong Kong-Macao Greater Bay Area peer – Shenzhen. Its clients include the French government.

Despite pandemic challenges, particularly in relation to logistics, the business managed to keep supplies moving. “I’m very proud of the fact that throughout the entire pandemic, we never had a delayed shipment to any of our clients,” Ms Martineau said.


Product diversification

As COVID-19 gradually shifts from pandemic to endemic, Ms Martineau said the business continues to evolve. “We see the focus shifting to prevention, management and control, and our team has been actively preparing to support this transition,” she said.

“Many of our European institutional clients – governments and healthcare providers – have learned their lesson and are actively preparing for the subsequent waves, so demand is still high.”

The company’s early research and development in 2020 and last year focused mainly on COVID-19, but now the business is turning its attention to other medical products.

“While we still have our core of anti-pandemic products and continue to pay close attention to how the virus evolves, we’re actively developing our non-COVID product ranges, including needles and syringes, in-vitro diagnostics and new categories such as advanced wound care, dental care and diagnostic tests,” she said.

“With this comprehensive and growing range of product categories, we are on a strong growth trajectory to becoming one of the world’s leading professional medical equipment providers.”

Ms Martineau emphasises the importance of community support. “Through the AquilaVIE Cares Community Partnership Programme, we set aside a certain percentage of production for charity so that qualified non-profits and community organisations could access our products. We donated about 50,000 test kits, 20,000 masks and face shields to partners including Caritas, Hong Kong Cancer Fund and the Salvation Army.”

Hong Kong advantage

When Ms Martineau first came to Asia in 1999, she was working in the diamond industry and spent a lot of time in Hong Kong. “From the moment that I landed in this city I knew that this was going to be home for me. I’ve always been fascinated with the dynamic and communitarian spirit in Asia, and Hong Kong exemplifies this energy perfectly,” she said.

“When I first arrived, the manufacturing industry in Mainland China was still in its infancy but you could already see its incredible potential. With Hong Kong being the main gateway city to the mainland, I decided to move to the city to navigate the complexity of sourcing and manufacturing highly technical products in the region.”

She said that working in the jewellery industry helped her develop a meticulous attention to detail, which she carried into her new business.

“This is an absolute necessity for medical devices because in healthcare, people’s lives depend on your products and services, so there is absolutely no room for mistakes. In healthcare, there are many trading companies looking to make a quick profit, especially during the early months of the pandemic. We came in to establish a trustworthy brand because people were looking for reassurance and accessibility.”

To date, France, Spain, Italy, Germany and the UK have been key AquilaVIE markets, while the AQ Lollipop 2-in-1 nasal and oral swab test has done well in Hong Kong, given that parents must test children for COVID-19 every day before school.

“I’m very excited that we’ve also established a subsidiary in the US and are now building a team to take our efforts to a new level. We see a great need for advancement care as the US is the largest market for insulin-related medical supplies. Another product category we see as promising is disposable medical devices such as syringes and gloves,” she noted.

Hong Kong is the place where Ms Martineau feels most at home, and its advantageous location made it a natural home for the business.

“It was without question that Hong Kong would serve as Aquila Healthcare’s headquarters, as it’s situated right between our production house in the mainland and our markets in Asia, Europe and the Americas. With our world-class healthcare institutions and access to an international talent pool, Hong Kong has all the elements to build a world-leading medical device company,” she said.

Post-pandemic, the world has taken a much more proactive approach to health, said the CEO. “Prevention is key today: all around the world, people have become more conscious about their wellbeing and are taking greater control over their health. We’re starting to see the benefit of identifying illnesses or health issues at an early stage.”

In addition to diversifying its product range, Ms Martineau said Aquila Healthcare is working closely with partners to create a sustainable ecosystem. “We’re moving towards biodegradable processes and product packaging, reducing energy consumption to control the carbon footprint and reinforcing a non-disruptive supply chain around the globe.”

Health will be front and centre next month at the Hong Kong Trade Development Council’s Asia Summit on Global Health and concurrent Hong Kong International Medical and Healthcare Fair which together comprise International Healthcare Work.

Related link
AquilaVIE

BACK TO TOP ^
CONTENT PROVIDED BY
    Topics:
  • Medical Supplies & Medicine,
  • Hong Kong,
  • Western Europe,
  • EU,
  • France,
  • health,
  • medicine,
  • start-ups,
  • FeatureGBA,
  • Success Stories,
  • FEATURECHINA
  • Medical Supplies & Medicine
  • Hong Kong
  • Western Europe
  • EU
  • Hong Kong
  • France
Home

Article Topics

ARTICLE TOPICS

MEDICAL SUPPLIES...24721
HONG KONG36026
WESTERN EUROPE36222
EU37804
FRANCE36228

ARTICLE TOPICS

MEDICAL SUPPLIES & MEDICINE24721
HONG KONG36026
WESTERN EUROPE36222
EU37804
FRANCE36228
HEALTH80159
MEDICINE82007
START-UPS98715
FEATUREGBA150838
SUCCESS STORIES117676
FEATURECHINA151961

interest_article

YOU MAY BE INTERESTED IN

01 December 2022

GBA grows into healthcare hub

24 November 2022

Health summit boosts medical hub credentials

04 November 2022

New fitness concept gains ground

24 October 2022

Painting a greener picture

Related Events

RELATED EVENTS

19 - 21 April 2023

Asian Licensing Conference 2023

16 - 25 May 2023

HKTDC Hong Kong International Medical and Healthcare Fair 2023 (Click2Match)

16 - 18 May 2023

HKTDC Hong Kong International Medical and Healthcare Fair 2023 (Physical Fair)

17 - 18 May 2023

Asia Summit on Global Health 2023
FIND AN EVENT

Social Share

FOLLOW US

GET WEEKLY UPDATES

newpaper-img

GET OUR WEEKLY EMAIL UPDATES

banner-img


I acknowledge that the above information may be used by the Hong Kong Trade Development Council (HKTDC) for incorporation in all or any of its database for direct marketing or business matching purpose (and may therefore become available to the public within and/or outside of Hong Kong for use by them), and for any other purposes as stated in the Privacy Policy Statement; I confirm that I have the consent and the authority of each individual named in this form to release their personal data for the purposes stated herein.


*For non-EU/EEA customers, please skip this box which is solely for EU/EEA customers as required by the relevant data protection law in the EU.

THANK YOU

Thank you for registering.

SHARE THIS STORY

EMAIL
LINKEDIN
WeChat
FACEBOOK
TWITTER
WHATSAPP

ID: HKTDCofficial

Don't have an account?

Create An Account

successfully added on your preferences.